These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12408044)

  • 1. B cell anergy and systemic lupus erythematosus.
    Seo SJ; Mandik-Nayak L; Erikson J
    Curr Dir Autoimmun; 2003; 6():1-20. PubMed ID: 12408044
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-affinity anti-Smith antigen B cells are regulated by anergy as opposed to developmental arrest or differentiation to B-1.
    Borrero M; Clarke SH
    J Immunol; 2002 Jan; 168(1):13-21. PubMed ID: 11751941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptors and activation of autoreactive B cells.
    Leadbetter EA; Rifkin IR; Marshak-Rothstein A
    Curr Dir Autoimmun; 2003; 6():105-22. PubMed ID: 12408049
    [No Abstract]   [Full Text] [Related]  

  • 4. Age-associated B cells expanded in autoimmune mice are memory cells sharing H-CDR3-selected repertoires.
    Aranburu A; Höök N; Gerasimcik N; Corleis B; Ren W; Camponeschi A; Carlsten H; Grimsholm O; Mårtensson IL
    Eur J Immunol; 2018 Mar; 48(3):509-521. PubMed ID: 29266242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheumatoid factors in health and disease: structure, function, induction and regulation.
    Haberman AM; William J; Euler C; Shlomchik MJ
    Curr Dir Autoimmun; 2003; 6():169-95. PubMed ID: 12408052
    [No Abstract]   [Full Text] [Related]  

  • 6. Signaling mutations and autoimmunity.
    Yu CC; Mamchak AA; DeFranco AL
    Curr Dir Autoimmun; 2003; 6():61-88. PubMed ID: 12408047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of complement in B cell activation and tolerance.
    Carroll MC
    Adv Immunol; 2000; 74():61-88. PubMed ID: 10605604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
    Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D
    J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice.
    Takahashi K; Kozono Y; Waldschmidt TJ; Berthiaume D; Quigg RJ; Baron A; Holers VM
    J Immunol; 1997 Aug; 159(3):1557-69. PubMed ID: 9233655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal B cell signal transduction in systemic lupus erythematosus.
    Khan IU; Tsokos GC; Kammer GM
    Curr Dir Autoimmun; 2003; 6():89-104. PubMed ID: 12408048
    [No Abstract]   [Full Text] [Related]  

  • 11. The origin of anti-nuclear antibodies in bcl-2 transgenic mice.
    Mandik-Nayak L; Nayak S; Sokol C; Eaton-Bassiri A; Madaio MP; Caton AJ; Erikson J
    Int Immunol; 2000 Mar; 12(3):353-64. PubMed ID: 10700470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-1 cellular origin and VH segment structure of IgG, IgA, and IgM anti-DNA autoantibodies in patients with systemic lupus erythematosus.
    Kasaian MT; Casali P
    Ann N Y Acad Sci; 1995 Sep; 764():410-23. PubMed ID: 7486556
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of human antibody variable genes in systemic autoimmunity.
    Zouali M
    Immunol Rev; 1992 Aug; 128():73-99. PubMed ID: 1427924
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of complement receptors CD21/CD35 in positive selection of B-1 cells.
    Reid RR; Woodcock S; Prodeus AP; Austen J; Kobzik L; Hechtman H; Moore FD; Carroll MC
    Curr Top Microbiol Immunol; 2000; 252():57-65. PubMed ID: 11187085
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of B cells in systemic lupus erythematosus and rheumatoid arthritis.
    Mandik-Nayak L; Ridge N; Fields M; Park AY; Erikson J
    Curr Opin Immunol; 2008 Dec; 20(6):639-45. PubMed ID: 18775493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for the Cr2 gene in modifying autoantibody production in systemic lupus erythematosus.
    Wu X; Jiang N; Deppong C; Singh J; Dolecki G; Mao D; Morel L; Molina HD
    J Immunol; 2002 Aug; 169(3):1587-92. PubMed ID: 12133988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective silencing of DNA-specific B lymphocytes delays lupus activity in MRL/lpr mice.
    Tchorbanov AI; Voynova EN; Mihaylova NM; Todorov TA; Nikolova M; Yomtova VM; Chiang BL; Vassilev TL
    Eur J Immunol; 2007 Dec; 37(12):3587-96. PubMed ID: 18034421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune complex-mediated co-ligation of the BCR with FcγRIIB results in homeostatic apoptosis of B cells involving Fas signalling that is defective in the MRL/Lpr model of systemic lupus erythematosus.
    Paunovic V; Carter NA; Thalhamer T; Blair D; Gordon B; Lacey E; Michie AM; Harnett MM
    J Autoimmun; 2012 Dec; 39(4):332-46. PubMed ID: 22647731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA antibodies focus on the light chain.
    Diamond B; Eilat D
    Lupus; 1997; 6(3):315-6. PubMed ID: 9296775
    [No Abstract]   [Full Text] [Related]  

  • 20. Cd72(c) is a modifier gene that regulates Fas(lpr)-induced autoimmune disease.
    Xu M; Hou R; Sato-Hayashizaki A; Man R; Zhu C; Wakabayashi C; Hirose S; Adachi T; Tsubata T
    J Immunol; 2013 Jun; 190(11):5436-45. PubMed ID: 23616572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.